Sinikka Green

Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study

G. Ralph Corey, Samantha Good, Hai Jiang et al. · Clinical Infectious Diseases · 2014 · 213 citations · Full text

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Omadacycline for Acute Bacterial Skin and Skin-Structure Infections

William O’Riordan, Sinikka Green, J. Scott Overcash et al. · New England Journal of Medicine · 2019 · 148 citations

Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus

G. Ralph Corey, Francis F. Arhin, Matthew A. Wikler et al. · International Journal of Antimicrobial Agents · 2016 · 34 citations

Antimicrobial Susceptibility, Single-dose Oritavancin, Healthcare-associated Infection +8

Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials

Gregory J. Moran, Carisa De Anda, Anita Das et al. · Infectious Diseases and Therapy · 2018 · 15 citations · Full text